ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Philips launches smart telemetry platform for cardiac monitoring that provides continuous, enterprise-wide connectivity beyond the bedside

September 4, 2025

Empowering clinical teams to respond to surges, track usage and ease workflows with user-friendly touchscreen technology for telemetry patients on the move

Cambridge, Massachusetts – Philips, a global leader in health technology, today announced the introduction of an innovative telemetry platform designed to help address critical challenges in healthcare – including staff shortages and alarm management. A key component of the solution is the next-generation Telemetry Monitor 5500 which offers a comprehensive, data-driven approach to operational performance and patient care for cardiac monitoring.

Telemetry overuse can burden frontline teams, overwhelm hospital operations, and jeopardize patient safety [1]. At the same time, care teams can face alarm and cognitive overload with an average of 350 alarms going off per patient per day [2]. The telemetry platform streamlines alarm management, delivers data-driven insights, and automates clinical tasks with operational simplicity and networking options. 

“We continue to hear how disruptive non-actionable alarms and repetitive tasks can be. This platform will be a game-changer, offering a unified solution built to optimize telemetry across the care continuum,” said Ajay Parkhe, Business Leader, Hospital Patient Monitoring at Philips. “The combination of advanced clinical decision support tools, data-driven analytics, and secure monitoring empowers health systems to deliver better care while improving efficiency and reducing alarm burden.” 

By integrating with Philips central monitoring unit solution, also known as the CMU, the telemetry platform is designed to support: 

  • Simplified workflows with a redesigned compact, wearable monitor with easy-to-use touchscreen and lightweight design to keep patients ambulating while under continuous surveillance
  • Scalable telemetry monitoring to expand the number of high-acuity beds based on demand, helping hospitals manage emergency department surges
  • Monitoring technicians with tools that filter non-actionable alarms to help create a calm healing environment
  • Data-driven decisions supported by retrospective monitoring insights that uncover trends in alarm activity, patient deterioration and telemetry utilization
  • Connected bedside coordination enabled by mobile workflows that support “act anywhere” capabilities within the hospital network for admissions, transfers, wave strip capture, and team communication – all delivered through the Care Assist mobile application

Philips also offers the technology for clinicians to monitor cardiac patients up to 30 days after discharge through Philips Mobile Cardiac Telemetry (MCOT)*. MCOT can be utilized to monitor a patient following an in-patient stay or ED evaluation to transition patients into an appropriate care pathway, maintaining a higher continuity of care for their patients. 

The Philips monitoring portfolio connects patient information across devices and systems with innovative support tools, early warning scoring, custom algorithms and unique data visualizations. The human-centric ecosystem is designed to dramatically transform care with predictive capabilities, workflow automation and situational awareness in a smart healing environment. Philips supports clinicians with innovative, sustainable solutions that help deliver better care to more people.

[1] AHA Telemetry Guidelines Improve Telemetry Utilization in the Inpatient Setting. AJMC. https://www.ajmc.com/view/aha-telemetry-guidelines-improve-telemetry-utilization-in-the-inpatient-setting
[2] Jones K. Alarm Fatigue a top patient safety hazard. CMAJ. 2014;183(6):178. doi:10.1503/cmaj.109-4696.

* Philips Mobile Cardiac Telemetry (MCOT) includes the MCOT device with SmartDetect algorithm. MCOT supports MCOT and Cardiac Event services, which include an end of service report, technician ECG review, and urgent/emergent notification of detected cardiac events when appropriate. The MCOT system is contraindicated for patients with potentially life-threatening arrhythmias requiring inpatient monitoring, and patients for whom the attending physician recommends should be hospitalized for ECG monitoring. However, it can be utilized by professionals for monitoring cardiac patients at home after discharge.

For further information, please contact:

Allison Johnson
Director, Monitoring Communications
Tel: +1 617-631-7305
E-mail: allison.johnson@philips.com 

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachment


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  226.97
+2.76 (1.23%)
AAPL  268.81
+5.99 (2.28%)
AMD  259.67
+6.75 (2.67%)
BAC  53.02
+0.45 (0.86%)
GOOG  269.93
+9.42 (3.62%)
META  750.82
+12.46 (1.69%)
MSFT  531.52
+7.91 (1.51%)
NVDA  191.49
+5.23 (2.81%)
ORCL  281.40
-1.93 (-0.68%)
TSLA  452.42
+18.70 (4.31%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.